John Bennetts

John is a director, founder and owner of a range of businesses across a variety of industries including biotechnology, financial services and manufacturing.

He is a director of ASX listed McMillan Shakespeare and is a founder and director of Australian biotechnology companies Cellestis Ltd (which has led the world in improving the diagnosis and treatment for tuberculosis) and Glutagen Pty Ltd which has developed pioneering technology to assist people with gluten sensitivities.

Prior to moving into business John practiced as a commercial lawyer and has degrees in Law and Economics.